Antonio Recchiuti

University of Chieti, Center for Advanced Studies and Technology, Department of Medical, Oral, and Biotechnological Science

Dr. Antonio Recchiuti is Assistant Professor in Clinical Pathology at the Department of Medical, Oral, and Biotechnological Science and at the Center for Advanced Studies and Technology, University of Chieti, Italy. Dr. Recchiuti earned his MS Degree in Pharmaceutical Chemistry and Technology and his PhD at the University of Chieti. He completed his postdoctoral training at the Brigham and Women’s Hospital – Harvard Medical school with Charles N Serhan, who discovered endogenous pro-resolving lipid mediators (SPM) resolvins, lipoxins, protectins, and maresins that are critical in the resolution of inflammation. As a postdoc, Dr. Recchiuti identified the receptors binding the endogenous SPM resolvin D1, his signaling, and modes of action in human and mouse systems (PNAS 2010, FASEB J 2011, Am J Pathol 2012). He then moved back to the University of Chieti, where he has been a Group Leader since 2014.  The broad mission of his research team is to define bioactivities of SPM within the inflammatory and immune response and to promote the development of innovative therapies for the treatment of inflammation-based human pathologies, including cystic fibrosis and sickle cell disease. He has received several awards, including the ERC Marie Curie Grant, the Novartis Prize for Young Pharmacologists, and the Brigham and Women’s Hospital Spring Research Excellence Award. His research is funded by grants from the Italian Cystic Fibrosis Foundation, the American Cystic Fibrosis Foundation, the Telethon Foundation, and the Italian Ministry of Health. Link to publications: https://orcid.org/0000-0002-1409-5261  

Domenico Mattoscio

University of Chieti, Center for Advanced Studies and Technology, Department of Medical, Oral, and Biotechnological Science

Domenico Mattoscio is Assistant Professor at the Department of Medical, Oral, and Biotechnological Science and at the Center for Advanced Studies and Technology, University of Chieti, Italy. Dr. Mattoscio received an MSc degree in Biology from the University of Molise, Italy, and then the PhD from the University of Chieti where he characterized the contribution of platelets to sustain chronic inflammation and failure in resolution in cystic fibrosis. He then moved to the European Institute of Oncology, Italy, where he dissected cellular pathways involved in viral-mediated tumorigenesis. After completion of his post-doctoral training, he moved back to the University of Chieti where his primary research interest is focused on the understanding of how the restoration of pro-resolution circuits is beneficial in chronic inflammatory disorders such as cystic fibrosis and cancer. The lab uses mouse models of disease coupled with multi-color flow cytometry, cell sorting, multiplex ELISA and RNA sequencing to detail the inflammatory response as a whole.